Invests in
Locations:
Min Investment:
$1,000,000.00Max Investment:
$20,000,000.00Target Investment:
$5,000,000.00
Education
- DU
Lists including Michael
Work Experience
2025
Associate Director, Portfolio Strategy & Analytics
2025
2022 - 2025
Associate
2022 - 2025
Early-stage biotech / life sciences investing. Seed - Series B. Sample technologies evaluated: Drug Discovery, Therapeutics, Platform Technologies, Biotech, Healthtech, Nutrition, Crop Science, Animal Health. Portfolio Support: GTM Strategy, Growth Strategy, Pipeline Prioritization, Indication Prioritization, Capital Allocation, Financial Modeling, NPV Analysis, Scenario Planning, Enterprise Strategy, Governance, Hiring.
2023 - 2023
MBA Intern
2023 - 2023
GTM Strategy, R&D Strategy, Fundraising & Governance.
2018 - 2022
Consultant
2021 - 2022
Life Sciences Team Project Lead, managing 3-5 team members Multiple strategy projects including: R&D portfolio prioritizations, supply chain / clinical trial strategy for a covid-19 vaccine manufacturer, M&A growth strategy for major MedTech company, Asset Screen for large Biopharma company 15+ due diligences across life sciences Skills: Scenario forecasting, NPV analysis & market modeling, GTM strategy, new product launch planning (NPP), revenue forecast, stakeholder management, storytelling & answer development, executive communication, cross-functional collaboration, competitive analysis, market landscape evaluation, data-driven decision-making, portfolio prioritization, Excel & PowerPoint Firm Involvement: Green Committee Head (global lead of all sustainability initiatives and carbon offsetting), Pan Mass Challenge Team Captain, Pride Committee
Senior Associate Consultant
2020 - 2021
Associate Consultant
2020 - 2020
Associate
2018 - 2020
2018 - 2018
Business Development Fellow
2018 - 2018
2017 - 2017
Inhouse Consulting Intern
2017 - 2017